Navigation Links
Study shows optimal dose management of warfarin improves anticoagulation control
Date:12/22/2008

Boston, MA Researchers from Boston University School of Medicine (BUSM) have determined the optimal dose-management strategy to derive maximal benefit from warfarin therapy and improve patient outcomes. Results of the study appear online in the December 2008 issue of the Journal of Thrombosis and Haemostasis.

Warfarin is highly effective to prevent strokes, treat venous thromboembolism and for other conditions. Numerous studies have focused on the underutilization of warfarin for patients with atrial fibrillation, the most common indication for warfarin. However, relatively little is known about how best to manage warfarin once it is initiated.

"This lack of evidence regarding optimal management strategies probably contributes to our limited success in maintaining patients within the therapeutic range," said lead author Adam Rose, Md, MSc, assistant professor of medicine at BUSM and core investigator in the Center for Health Quality, Outcomes and Economic Research at Bedford VA Medical Center. "Previous studies have clearly shown that time spent outside the therapeutic range contributes to more adverse events for patients, such as stroke and gastrointestinal hemorrhage. Therefore, increasing the time in the therapeutic range is of utmost importance."

Researchers studied 3,961 patients receiving warfarin from 94 community-based clinics and validated a model for the probability of a warfarin dose change under various conditions.

This model was then used to predict the number of dose changes each patient would have, based on characteristics of their clinic visits and anticoagulation control. The predicted number of dose changes was then compared to the actual number of times the dose was changed. Patients who deviated the least from the predicted number of dose changes achieved the best anticoagulation control and patients with greater deviations had worse anticoagulation control. On average, clinicians in the st
'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Vulnerability to post-traumatic stress disorder runs in families, study shows
2. Study: How Can States Treat a Sick Economy? Call the Doctors
3. Perception of health and balance has direct impact on walking activity, new study says
4. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients
5. New study shows that a cough medicine ingredient could effectively treat prostate cancer
6. Common treatment for mens pelvic pain proves ineffective, Queens-led study shows
7. Study indicates how we make proper movements
8. Study Finds Molecular Link Between Obesity, Hypertension
9. Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
10. Annals colonoscopy study underscores importance of quality standards
11. Study: Sandwich Generation Struggling With Dual Caregiver Responsibilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Greatist ... newsletter and website that helps active people find the most fun activities to do ... lifestyle coverage for millennials. It also increases Greatist’s opportunity for events, e-commerce, and brand ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... of advanced delivery technologies and development solutions for drugs, biologics and consumer ... with Excelimmune, Inc. to access its antibody combination therapy (ACT) technology platform. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud to ... Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating patients with ... conditions. , After receiving his Bachelor of Science in Biology from the University of ...
(Date:7/7/2015)... ... July 07, 2015 , ... Georgia Partnership for ... communities throughout Georgia, announces the launch of the first ambulance telemedicine program in ... County, GA. The new program will not only provide more immediate patient care, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Bayco’s Nightstick® ... the introduction of the Nightstick XPP-5422GM , the world’s first Intrinsically Safe ... its base and one on its clip. The new Nightstick XPP-5422GM is now ...
Breaking Medicine News(10 mins):Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 2Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 3
... Dermatologists say that paying extra for expensive vitamins in skin ... will get you little more than an empty wallet.//,Antioxidants are ... in the body and the skin.Free radicals are a result ... by exposure to various environmental factors such as smoking or ...
... are often concerned that toxins within the environment ... by these couples to their health care providers ... regarding the reproductive impact of potential environmental toxins ... ,Heavy metals such as lead and mercury, ...
... when someone who talks about suicide will actually go ... depressed patients need protection.Now American scientists believe that// they ... test that checks glands controlling the stress hormone cortisol. ... the mental turmoil that leads people to take the ...
... cells in the lens of the eye become cloudy. It ... states that eating a diet rich in Vitamin C could ... Nutrition looked at nearly 400 people aged between 53 and ... supplements they were taking. Overall, 35% had "cortical opacities", a ...
... a more effective vaccine for anthrax and they claim that ... which is presently available.It has been developed by a team, ... by Dr Rakesh Bhatnagar. ,It is made up of ... the toxin that does the damage to humans infected with ...
... a decreased white blood cell function can lead to ... at six weeks of age the// genetically engineered mice ... the normal mice had no bone loss. The ... is an indication of periodontitis. ,The scientists also ...
Cached Medicine News:
(Date:7/7/2015)... , July 7, 2015 Hill-Rom,s recent ... $2 billion in cash and stock means the ... market, according to Kalorama Information. The healthcare market ... the medical device and advanced wound care markets, ... beds, patient lifting devices, and other healthcare equipment. ...
(Date:7/7/2015)... , July 7, 2015  Shareholder rights law ... a federal securities fraud class action complaint was ... Southern District of California.  The complaint alleges that ... CLDN ) violated the Securities Exchange Act of ... 2015, by making materially false and misleading statements ...
(Date:7/7/2015)... 7, 2015 According to ... Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, ... Alpha Emitters, Brachytherapy - Y-90), by Application (Oncology, ... by MarketsandMarkets, this report studies the global Nuclear ... to 2020. This market is expected to reach ...
Breaking Medicine Technology:Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 2Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: